AGM/EGMJun 22, 2026, 07:01 AM
RedHill Biopharma Schedules Annual General Meeting for July 28
AI Summary
RedHill Biopharma Ltd. announced its Annual General Meeting of Shareholders will be held on July 28, 2026, in Tel-Aviv, Israel. Key proposals include the re-appointment of Kesselman & Kesselman as auditors, the re-election of Mr. Rick D. Scruggs and Dr. Shmuel Cabilly to the Board of Directors, and the approval of Mr. Dror Ben-Asher's engagement as Chairman and CEO. Shareholders will also review the financial statements for the fiscal year ended December 31, 2025.
Key Highlights
- Annual General Meeting (AGM) scheduled for July 28, 2026, at 3:00 p.m. Israel time.
- Shareholders to re-appoint Kesselman & Kesselman as auditors for 2026.
- Shareholders to approve re-election of Mr. Rick D. Scruggs and Dr. Shmuel Cabilly to the Board for a three-year term.
- Shareholders to approve the engagement of Mr. Dror Ben-Asher as Chairman of the Board and CEO.
- Shareholders of record as of June 23, 2026, are entitled to vote at the General Meeting.
- The Board of Directors recommends voting "FOR" all proposals.
Price Impact
More from RDHL